HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Oral Cancer Research

Oral cancer is a formidable health concern with significant global impact, prompting ongoing research to deepen our understanding of its complexities. Researchers strive to unravel the intricate mechanisms that underlie the development and progression of oral cancers, encompassing the lips, tongue, cheeks, and throat. Investigations delve into the multifaceted factors contributing to oral cancer, including tobacco and alcohol consumption, human papillomavirus (HPV) infection, and genetic predispositions. The goal is to identify key risk factors and enhance early detection strategies, ultimately improving patient outcomes. Genomic studies play a pivotal role, shedding light on the genetic alterations that drive oral cancer. Unraveling the intricacies of these genetic changes allows researchers to identify potential therapeutic targets, paving the way for more personalized and effective treatment approaches. In addition, biomarker research is gaining prominence, aiming to discover reliable indicators of oral cancer presence and progression. The development of precise biomarkers could revolutionize diagnostics, enabling earlier detection and intervention. Cutting-edge imaging technologies are also being explored to enhance the visualization of oral lesions, facilitating early identification and differentiation between benign and malignant tissues. This holds promise for refining diagnostic accuracy and guiding clinicians in treatment decision-making. Immunotherapy, a rapidly evolving field in cancer research, is being investigated for its potential in oral cancer treatment. Researchers aim to harness the power of the immune system to target and eliminate cancer cells, offering a novel therapeutic avenue for improved patient outcomes. Beyond treatment modalities, behavioral and lifestyle interventions are subjects of interest in oral cancer prevention. Understanding the impact of lifestyle choices on oral cancer risk may inform public health initiatives and promote proactive measures to mitigate the disease's incidence. As research in oral cancer continues to advance, the collective efforts of scientists, clinicians, and healthcare professionals hold the promise of transformative breakthroughs. Through ongoing investigations into the molecular, genetic, and environmental facets of oral cancer, the scientific community strives to improve prevention, early detection, and treatment strategies, ultimately reducing the burden of this formidable disease.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp